文献速递烧伤创面修复

噬菌体疗法在烧伤创面感染管理中的作用:优势与陷阱

The Role of Phage Therapy in Burn Wound Infections Management: Advantages and Pitfalls.
PubMed 文献 · J Burn Care Res · 2022-01-01

该系统性综述探讨噬菌体疗法在烧伤创面感染中的应用,包括噬菌体特性、与常规抗生素的比较、抗生物膜活性、给药方式及临床使用。尽管多个科学组织认可其价值,但缺乏共识性治疗指南/监管政策及预测疗效的实验室支持,阻碍了烧伤外科医生采用。

要点

  • 噬菌体疗法可单独或联合抗生素治疗烧伤创面感染,包括多重耐药菌感染。
  • 缺乏共识性治疗指南和监管政策是烧伤外科医生采用的主要障碍。
  • 需有使用方便、稳定性好且保质期 adequate 的产品制剂。

核心结论

  • 噬菌体疗法可能成为烧伤创面感染的有价值替代方案,但存在阻碍其被烧伤外科医生采用的陷阱。
  • 缺乏共识性治疗指南/监管政策及预测疗效的实验室支持是关键障碍。

研究设计与样本

  • 系统性综述,检索范围未在摘要中详述。

主要发现

  • 噬菌体疗法可单独或联合常规抗生素治疗特定细菌感染如烧伤创面感染,包括多重耐药菌所致感染。
  • 多个科学组织/学会认可噬菌体疗法在现代创面护理中可能具有关键价值。

关键数值与推荐

  • 需有使用方便、稳定性 adequate 且保质期 adequate 的产品/制剂。
  • 缺乏共识性治疗指南/监管政策及预测疗效的实验室支持。

临床怎么用

  • 烧伤外科医生可考虑噬菌体疗法作为烧伤创面感染的替代或辅助治疗。
  • 应用前需关注制剂稳定性、保质期及实验室支持预测疗效。

局限性

  • 缺乏共识性治疗指南和监管政策。
  • 缺乏预测噬菌体疗法疗效的实验室支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Burn wound infections are often the source of bacteria responsible for systemic infections, including bloodstream infections and pneumonia that ultimately can result in multisystem organ failure and death. Any rapid change in the burn wound appearance or the clinical condition of the burn patient may herald burn wound infection or sepsis. The revival of phage therapy, either in single mode or in combination with conventional antibiotics may represent a valuable alternative, to treat specific bacterial infections such as burn wound infections, including those caused by multidrug-resistant organisms. This systematic review addresses the: 1) general characteristics of bacteriophages; 2) activity of bacteriophages vs conventional antibiotics; 3) activity of bacteriophages against biofilms; 4) bacteriophage administration; and 5) use of bacteriophages in burn wound infections. Although several scientific organizations/societies recognized that phage therapy could be of key value in modern wound care, specific aspects are critical for a burn surgeon and might represent pitfalls discouraging phage therapy adoption in burn wound management; in particular, the unavailability of consensual therapeutic guidelines/regulatory policies and the lack of laboratorial support that might be predictive of its efficacy. The availability of a product/formulation convenient to use, with adequate stability and shelf half-life is also a key condition.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Azevedo MM, Pina-Vaz C, Rodrigues AG, et al. The Role of Phage Therapy in Burn Wound Infections Management: Advantages and Pitfalls. J Burn Care Res. 2022. PMID: 34523679. doi:10.1093/jbcr/irab175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。